- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Table of Contents
Salvestrols
Salvestrols are a new class of natural anticancer chemicals, which are found in plants and safely eaten in the diet*. Initially non-toxic to the body’s normal cells, Salvestrols become activated inside human cancer cells by an enzyme, CYP1B1 (pronounced “sip one bee one”). The activated Salvestrols then cause the cancer cells to stop growing or die, without harming normal cells. This specificity of action is possible because CYP1B1 is an intrinsic component of cancer cells and occurs in all of the wide range of different types of cancer that have been studied to date, but is absent from normal cells.
sources
* blackcurrant, blueberry, strawberry, and tangerine peel have been used as the basis of commercial products.
extracts and pharmaceuticals
“ A 2007 BBC News story reported on a laboratory study that had found salvestrols extracted from tangerine peel show anti-cancer effects… on cells ..in the laboratory”
“Enthusiasm for resveratrol, the first salvestrol discovered, decreased substantially with additional scientific investigation. A large clinical trial of a resveratrol-based pharmaceutical, SRT-501, was halted when it showed no anti-cancer activity and had significant side effects… … In a 2013 Royal Society of Chemistry podcast, Philip Broadwith stated that “despite the lack of reliable data on resveratrol's effects in humans, the compound is still marketed as a dietary health supplement”
from wikipedia
Antibiotics that are okay under special circumstances
Curative treatments must generate immunopathology
<html><div class=“mainarticle”>Main section:</html> Vitamin D Receptor agonist
According to the Marshall PathogenesisA description for how chronic inflammatory diseases originate and develop., patients must generate immunopathology in order to recover from chronic inflammatory disease. To this end, regular dosing of olmesartan (Benicar)Medication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. is critical. OlmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. 's action as a VDR agonistA substance such as olmesartan (Benicar) or 1,25-D which activates the Vitamin D Receptor and transcribes the genes necessary for a proper innate immune response. allows Marshall Protocol patients to activate their innate immune responseThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease.. This is evident in patients taking MP antibiotics who do not begin killing bacteria until they take olmesartan.